Gastric pacing for diabetic gastroparesis--does it work?

Area of Science:

• Gastroenterology
• Medical Devices
• Diabetes Management

Background:

• Diabetic gastroparesis resistant to medical therapy presents significant management challenges.
• Gastric electrical stimulation (GES) is an emerging therapeutic option with promising international trial results.
• Limited data exists on GES effectiveness in the Irish healthcare setting.

Purpose of the Study:

• To evaluate the impact of GES on inpatient stay duration and cost.
• To assess the effect of GES on glycaemic control (HbA1c) in patients with diabetic gastroparesis.
• To determine the overall efficacy of GES in a small cohort of Irish patients.

Main Methods:

• Retrospective case note review of four patients who underwent GES.
• Calculation of inpatient days for symptomatic gastroparesis pre- and post-GES.
• Analysis of total inpatient admission costs and average HbA1c levels before and after GES.

Main Results:

• Mean inpatient stay was 81.75 days pre-GES and 62.25 days post-GES (p=0.89), showing no significant difference.
• No improvement in glycaemic control (HbA1c) was observed following GES.
• GES demonstrated ineffectiveness in reducing inpatient stay duration and improving glycaemic control in this cohort.

Conclusions:

• Gastric electrical stimulation (GES) was ineffective in improving length of inpatient stay for diabetic gastroparesis patients in this study.
• GES did not lead to better glycaemic control in the evaluated patient cohort.
• Further research is needed to clarify the role of GES in managing refractory diabetic gastroparesis.